Noramco Inc has applied to the Drug Enforcement Administration (DEA) to become a bulk manufacturer of certain controlled substances, including synthetic versions of Marihuana Extract, Marihuana, and Tetrahydrocannabinols. The company intends to produce these substances as active pharmaceutical ingredients and reference standards for their customers. Interested parties are invited to submit comments, objections, or a request for a hearing regarding this application by April 6, 2021. Written comments should be sent to the DEA's Federal Register Representative in Springfield, Virginia.
Simple Explanation
Noramco Inc wants permission from the government to make special medicines from substances like Marihuana extracts. People can tell the government if they have questions or problems about this request before April 6, 2021.